Consistent
EditCo is your exclusive hub for research and discovery tools. Enjoy exceptional service, leadership, and infrastructure with a sharp, specialized focus on providing reliable CRISPR Reagents and Engineered Cells quickly and efficiently.
Comprehensive
From Knockout and Knock-in Immortalized Cells to Primary Cells and CRISPR Reagents, EditCo offers a wide range of gene editing services and products to meet diverse research needs. Whatever you edit, we can make it easier to jump-start your research process.
Collaborative
Whether partnering with our development team for custom editing or connecting to our Discovery Partnership Ecosystem for leading cell assays and services, our customers benefit from our commitment to deliver real solutions.
As researchers studying SURF2's role in cancer resistance to chemotherapy, we investigated its depletion in U2OS and HepG2 cell lines. While siRNA yielded initial insights, we sought a more robust approach and partnered with EditCo to generate CRISPR knockout pools. They provided 100% homozygous deletions quickly, allowing us to validate results, isolate clones, and assess SURF2 knockout effects. This work led to our publication in Nature Communications (Tagnères et al.) and continues to drive our research. EditCo’s expertise and efficiency were instrumental, and we look forward to future collaborations.
EditCo has proven to be an invaluable partner in advancing our—and our client's—research. We highly recommend their gene editing services to any organization seeking a reliable, efficient, and skilled collaborator in the field of gene editing.
ATCC and EditCo’s strategic partnership brings together the gold standard in authenticated cell lines with EditCo’s leading CRISPR tools and gene editing services. This powerful alliance allows researchers to harness the highest-quality edited cells, accelerating their research with unparalleled speed, precision, reproducibility, and quality.
We chose EditCo's Arrayed CRISPR Library for our screening project after testing different reagents and finding that the multi-guide RNA design results in superior editing and knockout efficiency. This superior efficiency improves the sensitivity of our screen by enhancing our ability to detect phenotypes—in particular, weak phenotypes—resulting from knockouts.
.svg)
Partners
Partners in Innovation
When you partner with EditCo, you harness the transformative power of genome engineering for life science R&D and drive forward human health advancements. Through our Discovery Partners Ecosystem, we offer a unified platform from engineered cells to phenotypic data, streamlining the research process to accelerate drug discovery.
